We serve 1H-1,2,3-Triazole CAS:288-36-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Product Name: 1H-1,2,3-Triazole
Synonym: 1,2,3-1H-triazole; Intermediate of Tazobactam
Cas No.: 288-36-8
Formula: C2H3N3
MW: 69.07
EINECS No.:608-262-3
HS Code: 2933990099
UN No.: 3077
Hazard class: 9 categories
Packing level: Class III
Specification
Appearance: Appearance
Purity: ≥99.0%
Water: ≤0.5%
Application
1,2,3-Triazole finds use in research as a building block for more complex chemical compounds, including pharmaceutical drugs such as tazobactam.
Intermediate of Tazobactam.
Packaging
25 kg/barrel, can also be packaged according to customer requirements.
Storage
Store in a cool, ventilated warehouse.
Keep away from fire and heat.
The temperature should not exceed 37 °C.
Contact us for information like 1H-1,2,3-Triazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Intermediate of Tazobactam physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1H-1,2,3-Triazole Use and application,1,2,3-1H-triazole technical grade,usp/ep/jp grade.
Related News: Ten domestic API leading enterprises of CSPC, Puluo Pharmaceutical, Huahai Pharmaceutical, Chuang Nuo Pharmaceutical, Federal Pharmaceuticals, Zhejiang Pharmaceutical, Yifan Pharmaceutical, Jiangxi Tianxin, Zhejiang Chemical Industry, and Xinhua Pharmaceutical rank among China’s API exporters The top ten in the list.METHYL 2-ISOTHIOCYANATO PROPIONATE manufacturer The oral form of rigosertib was developed to provide a potentially more convenient dosage form for use where the duration of treatment may extend to multiple years.(S)-(-)-1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid supplier The oral form of rigosertib was developed to provide a potentially more convenient dosage form for use where the duration of treatment may extend to multiple years.2-Bromocarbazole vendor The oral form of rigosertib was developed to provide a potentially more convenient dosage form for use where the duration of treatment may extend to multiple years.The risk to the general public remains low. And we continue to be confident we are in a good position to respond to this developing situation.”
